Global Fund reports success of latest HIV, TB and malaria investments:
This article was originally published in Clinica
The direct investments associated with around 400 grants for HIV/AIDS, TB and malaria programmes have resulted in unprecedented improvements in performance. So announced the Global Fund yesterday, during a United Nations meeting that is being held this week in New York to discuss progress in these areas of care. Over the last six months, 1.4 million people (up 43% since December 2005) are reportedly being treated for TB under the WHO's gold-standard DOTS programme, and 544,000 more people (up 42%) are receiving antiretroviral treatment for HIV/AIDS.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.